Company
Tango Therapeutics, Inc. (TNGX)
Standardized SEC financial data for Tango Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001819133 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $37.0M | $24.9M | $36.5M | $42.1M | $62.4M |
| R&D expense | $50.0M | $77.6M | $105.9M | $115.2M | $143.9M | $132.2M |
| SG&A expense | $9.9M | $17.6M |
Standardized from Tango Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $145.0M | $64.0M | $69.8M | $257.9M | $343.1M |
| Total current assets |
Get TNGX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TNGX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TNGX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"